CPA4 is a Novel Diagnostic and Prognostic Marker for Human Non-Small-Cell Lung Cancer

Background. Carboxypeptidase A4 (CPA4) belongs to a member of the metallocarboxypeptidase family, and its expression in lung cancer samples and clinical significance are still not investigated until now. In this study, we aimed to evaluate the level of CPA4 in non-small-cell lung cancer (NSCLC) samp...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Lichao, Wang, Yipeng, Yuan, Hebao, Burnett, Joseph, Pan, Jian, Yang, Zhihua, Ran, Yuliang, Myers, Ila, Sun, Duxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4934027/
https://www.ncbi.nlm.nih.gov/pubmed/27390594
http://dx.doi.org/10.7150/jca.15209

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4934027/
https://www.ncbi.nlm.nih.gov/pubmed/27390594
http://dx.doi.org/10.7150/jca.15209

Ejemplares similares